USSTOCK.TODAY
Market Closed
Log in Sign up

RF Acquisition Corp II(RFAI) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today

RFAI
RFAI
RF Acquisition Corp II
At close Nov 18 at 4:00 PM ET (Korea 11/19 06:00)
$33.70
+6.48 ▲ +23.81%
Nov 18 at 4:00 PM ET (Korea 11/19 06:00)
$33.70
+0.00 +0.00%

Full metrics table

Index ⓘ -P/E ⓘ 1158.08EPS (ttm) ⓘ 0.03Insider Own ⓘ 40.94%Shs Outstand ⓘ 7.5MPerf Week ⓘ -11.32%
Market Cap ⓘ 0.12BForward P/E ⓘ -EPS next Y ⓘ -Insider Trans ⓘ -Shs Float ⓘ 2.4MPerf Month ⓘ 5.71%
Enterprise Value ⓘ 0.12BPEG ⓘ -EPS next Q ⓘ -Inst Own ⓘ 45.8%Short Float ⓘ 0.23%Perf Quarter ⓘ 164.73%
Income ⓘ 0.00BP/S ⓘ -EPS this Y ⓘ -Inst Trans ⓘ -Short Ratio ⓘ 0.07Perf Half Y ⓘ 208.61%
Sales ⓘ 0.00BP/B ⓘ 8.28EPS next 5Y ⓘ -ROA ⓘ 0.36%Short Interest ⓘ 0.01MPerf YTD ⓘ 213.49%
Book/sh ⓘ 4.07P/C ⓘ 5918.55EPS past 3/5Y ⓘ -ROE ⓘ 0.39%52W High ⓘ -53.84% ($73.00)Perf Year ⓘ 212.91%
Cash/sh ⓘ 0.01P/FCF ⓘ -Sales past 3/5Y ⓘ -ROIC ⓘ 0.78%52W Low ⓘ 276.96% ($8.94)Perf 3Y ⓘ -
Dividend Est. ⓘ -EV/EBITDA ⓘ -EPS Y/Y TTM ⓘ -86.94%Gross Margin ⓘ -Volatility(W/M) ⓘ 13.73% 17.67%Perf 5Y ⓘ -
Dividend TTM ⓘ -EV/Sales ⓘ -Sales Y/Y TTM ⓘ -Oper. Margin ⓘ -ATR (14) ⓘ 5.51Perf 10Y ⓘ -
Dividend Ex-Date ⓘ -Quick Ratio ⓘ 0.04EPS Q/Q ⓘ -116.79%Profit Margin ⓘ -RSI (14) ⓘ 51.33Recom ⓘ -
Dividend Gr. 3/5Y ⓘ -Current Ratio ⓘ 0.04Sales Q/Q ⓘ -SMA20 ⓘ 4.88% ($32.13)Beta ⓘ 1.65Target Price ⓘ -
Payout ⓘ -Debt/Eq ⓘ 0Earnings ⓘ -SMA50 ⓘ -1.24% ($34.12)Rel Volume ⓘ 0.28Prev Close ⓘ $27.22
Employees ⓘ 2LT Debt/Eq ⓘ 0EPS/Sales Surpr. ⓘ -SMA200 ⓘ 78.83% ($18.84)Avg Volume(3M) ⓘ 0.08MPrice ⓘ $33.7
IPO ⓘ 2024/7/5Option/Short ⓘ No/YesTrades ⓘ 1465Volume ⓘ 21,235Change ⓘ 23.81%
Company
RFAI RFAIRF Acquisition Corp II | NASD | Shell Companies Deep dive

🧬 This is a special purpose acquisition company (SPAC) pursuing a merger with Nanyang Biologics, a Singapore-based innovative AI-driven drug discovery company. The goal is to bring its unique platform technology—which leverages artificial intelligence to identify therapeutic compounds from natural products—to the public markets, driving innovation in the biotech industry.

Quote

Over the past 1 year, roughly in the middle

54% below its 1-year high.

Now $33.70
52w low$8.9452w high$73.00
52W Range39%
Volume ⓘ 21,235

Traded less than usual. That is 28% of its average volume.

Company yardsticks do not fit here, so profitability, valuation and earnings are left out. The other verdicts still apply.

ETFs holding this stock 3 ETFs

Multiple ETFs hold this stock, but only a sliver

Buying this ETF gives you exposure to this stock as well.

Peer comparison Shell Companies

It ranks #1212 of 1429 in the industry

Based on market cap of $118M.

FAQ

FAQ

What kind of company is RFAI?

RFAI belongs to the Financial sector and operates in the Shell Companies industry.

What is the market cap of RFAI?

The market cap of RFAI is approximately $118M, ranking 4,327 within its sector.

What is the P/E ratio of RFAI?

RFAI has a P/E ratio of approximately 1158.1x, which can be used to assess its valuation relative to the Financial sector average.

What is the 52-week high and low for RFAI?

RFAI has recorded a 52-week high of $73.00 and a low of $8.94.

Telegram KakaoTalk
Briefs · earnings · signals, first Telegram · KakaoTalk channels